PT - JOURNAL ARTICLE AU - Hippchen, Theresa AU - Altamura, Sandro AU - Muckenthaler, Martina U. AU - Merle, Uta TI - Hypoferremia predicts hospitalization and oxygen demand in COVID-19 patients AID - 10.1101/2020.06.26.20140525 DP - 2020 Jan 01 TA - medRxiv PG - 2020.06.26.20140525 4099 - http://medrxiv.org/content/early/2020/06/26/2020.06.26.20140525.short 4100 - http://medrxiv.org/content/early/2020/06/26/2020.06.26.20140525.full AB - Background Iron metabolism might play a crucial role in cytokine release syndrome in COVID-19 patients. Therefore we assessed iron metabolism markers in COVID-19 patients for their ability to predict disease severity.Methods COVID-19 patients referred to the Heidelberg University Hospital were retrospectively analyzed. Patients were divided into outpatients (cohort A, n=204), inpatients (cohort B, n=81), and outpatients later admitted to hospital because of health deterioration (cohort C, n=23).Results Iron metabolism parameters were severely altered in patients of cohort B and C compared to cohort A. In multivariate regression analysis including age, gender, CRP and iron-related parameters only serum iron and ferritin were significantly associated with hospitalization. ROC analysis revealed an AUC for serum iron of 0.894 and an iron concentration <6µmol/l as the best cutoff-point predicting hospitalization with a sensitivity of 94.7% and a specificity of 67.9%. When stratifying inpatients in a low- and high oxygen demand group serum iron levels differed significantly between these two groups and showed a high negative correlation with the inflammatory parameters IL-6, procalcitonin, and CRP. Unexpectedly, serum iron levels poorly correlate with hepcidin.Conclusion We conclude that measurement of serum iron can help predicting the severity of COVID-19. The differences in serum iron availability observed between the low and high oxygen demand group suggest that disturbed iron metabolism likely plays a causal role in the pathophysiology leading to lung injury.KEY POINTSIron metabolism parameters are severely altered in COVID-19 patients.Measurement of serum iron can help predicting the severity of COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementMUM acknowledges funding from the Deutsche Forschungsgemeinschaft (SFB1036, SFB1118) and from the Federal Ministry of Education and Research (NephrESA project Nr 031L0191C). Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Data analysis was approved (number S-148/2020) by the Ethics Committee of the Medical Faculty Heidelberg.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data will be available upon request after final publication in a peer reviewed journal.